| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH6 ABCA4 MYO5A ANXA1 CHD8 CHD7 SMARCAD1 DNAH7 ABCB4 ATAD3B ATAD3C ABCA5 CCT8 ABCB11 ATP13A3 TNNT2 | 1.01e-05 | 614 | 178 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.10e-05 | 38 | 178 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH3 FLNC MYH6 NCALD NRAP MYO5A DAG1 PFN1 DAAM2 AFDN MYO18B TNNT2 TNS1 EPB41L1 | 2.69e-05 | 479 | 178 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1D MYH2 MYH3 FLNC MYH6 NCALD NRAP MYO5A RTCB GAPDH PACSIN1 NUMA1 DAG1 PFN1 PLEKHM2 FAM161A MID1 DAAM2 AFDN MYO18B TNNT1 TNNT2 TNS1 EPB41L1 | 4.45e-05 | 1099 | 178 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.39e-05 | 49 | 178 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | flavonoid binding | 7.90e-05 | 2 | 178 | 2 | GO:0097243 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.12e-05 | 118 | 178 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.09e-04 | 11 | 178 | 3 | GO:0180030 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 ABCA4 CHD8 CHD7 SMARCAD1 DNAH7 ABCB4 ATAD3B ATAD3C ABCA5 CCT8 ABCB11 ATP13A3 | 1.70e-04 | 441 | 178 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | vinculin binding | 1.87e-04 | 13 | 178 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 2.36e-04 | 3 | 178 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | protein domain specific binding | CACNA1D MYO5A GAPDH INPP5A ACOX1 NUMA1 HNRNPM DAG1 CASP5 CHD8 LCK ELMO1 SYNJ1 CEP250 CNTNAP2 AFDN BAIAP2 NIPBL | 8.49e-04 | 875 | 178 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | actin filament binding | 1.01e-03 | 227 | 178 | 8 | GO:0051015 | |
| GeneOntologyBiologicalProcess | muscle cell development | MYH3 FLNC MYH6 NRAP MYOM1 FDPS AGT CNTNAP2 HEY2 MYO18B TNNT1 TNNT2 FER1L5 | 4.77e-07 | 259 | 180 | 13 | GO:0055001 |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PRPSAP2 MYH3 MYH6 AMPD3 PNLIPRP2 GAPDH ACAT1 ENPP1 ACLY INPP5A PGAP4 OGDH TTC7A KAT2B FASN PLA2G4C SYNJ1 PIK3C2A FDPS PI4KA DHODH SCP2 HSD17B12 PPIP5K1 ENO1 IPMK IP6K2 | 2.26e-06 | 1142 | 180 | 27 | GO:0019637 |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | PRPSAP2 AMPD3 GAPDH ACAT1 ACLY PGAP4 TTC7A PLA2G4C SYNJ1 PIK3C2A FDPS PI4KA DHODH SCP2 HSD17B12 PPIP5K1 ENO1 IPMK IP6K2 | 3.82e-06 | 644 | 180 | 19 | GO:0090407 |
| GeneOntologyBiologicalProcess | inositol phosphate metabolic process | 5.93e-06 | 52 | 180 | 6 | GO:0043647 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.10e-06 | 15 | 180 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 FLNC MYH6 NRAP MYOM1 PFN1 TGFB3 MYO18B TNNT1 TNNT2 EPB41L1 | 8.50e-06 | 239 | 180 | 11 | GO:0031032 |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | MYO5A ACAT1 ANXA1 ACLY POR PGAP4 TTC7A KAT2B FASN PLA2G4C SYNJ1 PIK3C2A FDPS PI4KA SDR42E2 AGT SCP2 ABCB11 HSD17B12 IP6K2 B4GALT4 | 9.01e-06 | 813 | 180 | 21 | GO:0008610 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYH3 FLNC MYH6 NRAP MYOM1 PIEZO1 KAT2A FDPS AGT CNTNAP2 HEY2 MYO18B TNNT1 TNNT2 | 9.11e-06 | 391 | 180 | 14 | GO:0051146 |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.03e-05 | 86 | 180 | 7 | GO:0030239 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.25e-05 | 59 | 180 | 6 | GO:0045214 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.29e-05 | 89 | 180 | 7 | GO:0055002 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | MYO5A ACAT1 ANXA1 ENPP1 ACLY ACOX1 POR CPT2 KAT2B FASN PLA2G4C AGT SCP2 ABCB11 HSD17B12 | 1.35e-05 | 461 | 180 | 15 | GO:0006631 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.56e-05 | 18 | 180 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 MYO5A PACSIN1 ANXA1 CASP5 PFN1 ELMO1 TGFB3 TBCK SCN7A DAAM2 BAIAP2 MYO18B TNNT1 TNNT2 EPB41L1 | 1.58e-05 | 912 | 180 | 22 | GO:0030029 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH3 FLNC MYH6 NRAP MYOM1 PIEZO1 KAT2A HEY1 FDPS AGT CNTNAP2 HEY2 MYO18B TNNT1 TNNT2 FER1L5 | 1.79e-05 | 531 | 180 | 16 | GO:0042692 |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1D MYH2 MYH3 MYH6 MYOM1 DAG1 LCK PIK3C2A FDPS AGT SCN7A HEY2 TNNT1 TNNT2 ENO1 FKBP1B | 2.56e-05 | 547 | 180 | 16 | GO:0003012 |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | MYO5A GAPDH ANXA1 ACLY POR BCAT2 KAT2A KAT2B FASN FDPS AGT SCP2 ABCB11 HSD17B12 PPIP5K1 ENO1 IPMK IP6K2 | 2.75e-05 | 676 | 180 | 18 | GO:0044283 |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1D MYH2 MYH3 MYH6 MYOM1 LCK PIK3C2A AGT SCN7A TNNT1 TNNT2 ENO1 FKBP1B | 5.22e-05 | 400 | 180 | 13 | GO:0006936 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 6.96e-05 | 156 | 180 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 6.96e-05 | 156 | 180 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | MYH6 RTCB KDM4C CHD8 CHD7 KAT2A CPT2 TGFB3 HEY1 CNTNAP2 TXNRD3 HEY2 C5 MYO18B USPL1 ENO1 | 7.11e-05 | 596 | 180 | 16 | GO:0001701 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | MYO5A GAPDH ACAT1 ANXA1 ENPP1 ACLY ACOX1 POR CPT2 OGDH KAT2B FASN PLA2G4C AGT SCP2 ABCB11 HSD17B12 ENO1 | 7.55e-05 | 731 | 180 | 18 | GO:0032787 |
| GeneOntologyBiologicalProcess | umbilical cord morphogenesis | 7.57e-05 | 2 | 180 | 2 | GO:0036304 | |
| GeneOntologyBiologicalProcess | umbilical cord development | 7.57e-05 | 2 | 180 | 2 | GO:0061027 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane hyperpolarization | 7.57e-05 | 2 | 180 | 2 | GO:1902632 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH3 FLNC MYH6 NRAP MYOM1 MYO5A PACSIN1 ANXA1 CASP5 PFN1 ELMO1 TGFB3 TBCK DAAM2 BAIAP2 MYO18B TNNT1 TNNT2 EPB41L1 | 8.02e-05 | 803 | 180 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 1.27e-04 | 170 | 180 | 8 | GO:0046488 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | MYH6 RTCB KDM4C CHD8 CHD7 KAT2A CPT2 PFN1 TGFB3 HEY1 CNTNAP2 TXNRD3 HEY2 KDM2B C5 MYO18B USPL1 ENO1 NIPBL IPMK | 1.32e-04 | 906 | 180 | 20 | GO:0043009 |
| GeneOntologyBiologicalProcess | inositol phosphate biosynthetic process | 1.47e-04 | 31 | 180 | 4 | GO:0032958 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 1.64e-04 | 59 | 180 | 5 | GO:0055010 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | MYH6 RTCB KDM4C CHD8 CHD7 KAT2A CPT2 PFN1 TGFB3 HEY1 CNTNAP2 TXNRD3 HEY2 KDM2B C5 MYO18B USPL1 ENO1 NIPBL IPMK | 1.85e-04 | 929 | 180 | 20 | GO:0009792 |
| GeneOntologyBiologicalProcess | response to muscle activity | 2.12e-04 | 34 | 180 | 4 | GO:0014850 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 2.65e-04 | 143 | 180 | 7 | GO:0009185 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | PNLIPRP2 INPP5A PGAP4 TTC7A PLA2G4C SYNJ1 PIK3C2A FDPS PI4KA SCP2 IPMK IP6K2 | 2.68e-04 | 410 | 180 | 12 | GO:0006644 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol biosynthetic process | 2.75e-04 | 15 | 180 | 3 | GO:0045542 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol biosynthetic process | 2.75e-04 | 15 | 180 | 3 | GO:0106120 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 2.78e-04 | 66 | 180 | 5 | GO:0046854 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | ENPP1 ACLY INPP5A RDH5 POR SYNJ1 ABCA5 FDPS SCP2 PPIP5K1 IPMK IP6K2 | 2.80e-04 | 412 | 180 | 12 | GO:0006066 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PRPSAP2 MYH3 MYH6 AMPD3 GAPDH ACAT1 ENPP1 ACLY OGDH KAT2B FASN DHODH HSD17B12 ENO1 | 2.90e-04 | 540 | 180 | 14 | GO:0019693 |
| GeneOntologyBiologicalProcess | positive regulation of small molecule metabolic process | 2.91e-04 | 192 | 180 | 8 | GO:0062013 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 3.40e-04 | 149 | 180 | 7 | GO:0009132 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.99e-04 | 153 | 180 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | SEL1L PNLIPRP2 INPP5A ESR1 PGAP4 TTC7A PLA2G4C SYNJ1 PIK3C2A PI4KA IPMK IP6K2 | 4.03e-04 | 429 | 180 | 12 | GO:0046486 |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 4.06e-04 | 17 | 180 | 3 | GO:0003222 | |
| GeneOntologyBiologicalProcess | alcohol biosynthetic process | 4.15e-04 | 154 | 180 | 7 | GO:0046165 | |
| GeneOntologyBiologicalProcess | endocardial cushion to mesenchymal transition involved in heart valve formation | 4.49e-04 | 4 | 180 | 2 | GO:0003199 | |
| GeneOntologyBiologicalProcess | Cajal body organization | 4.49e-04 | 4 | 180 | 2 | GO:0030576 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.53e-04 | 112 | 180 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 4.81e-04 | 260 | 180 | 9 | GO:0072330 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | ENPP1 ACLY ESR1 RDH5 POR ABCA5 FDPS SDR42E2 SCP2 ABCB11 HSD17B12 | 4.84e-04 | 376 | 180 | 11 | GO:0008202 |
| GeneOntologyBiologicalProcess | ADP catabolic process | 4.97e-04 | 114 | 180 | 6 | GO:0046032 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | MYO5A ENPP1 ACLY INPP5A RDH5 POR SYNJ1 ABCA5 FDPS SCP2 ABCB11 PPIP5K1 RNF180 IPMK IP6K2 | 5.19e-04 | 641 | 180 | 15 | GO:1901615 |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | PNLIPRP2 INPP5A PGAP4 TTC7A PLA2G4C SYNJ1 PIK3C2A PI4KA IPMK IP6K2 | 5.25e-04 | 320 | 180 | 10 | GO:0006650 |
| GeneOntologyBiologicalProcess | muscle structure development | MYH3 FLNC MYH6 NRAP MYOM1 PIEZO1 DAG1 CHD7 KAT2A HEY1 FDPS AGT CNTNAP2 HEY2 MYO18B TNNT1 TNNT2 FER1L5 | 5.32e-04 | 858 | 180 | 18 | GO:0061061 |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 5.36e-04 | 76 | 180 | 5 | GO:0003229 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 5.69e-04 | 77 | 180 | 5 | GO:0055008 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 5.71e-04 | 117 | 180 | 6 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 5.71e-04 | 117 | 180 | 6 | GO:0009181 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition involved in endocardial cushion formation | 5.71e-04 | 19 | 180 | 3 | GO:0003198 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 5.98e-04 | 268 | 180 | 9 | GO:0008654 | |
| GeneOntologyBiologicalProcess | lipid modification | 5.99e-04 | 214 | 180 | 8 | GO:0030258 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 6.21e-04 | 327 | 180 | 10 | GO:0048738 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 6.52e-04 | 120 | 180 | 6 | GO:0046031 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol metabolic process | 6.68e-04 | 20 | 180 | 3 | GO:0090205 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation | 6.78e-04 | 80 | 180 | 5 | GO:0006635 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid biosynthetic process | 6.82e-04 | 121 | 180 | 6 | GO:0046889 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 6.82e-04 | 121 | 180 | 6 | GO:0009191 | |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 7.12e-04 | 122 | 180 | 6 | GO:0019395 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 7.12e-04 | 122 | 180 | 6 | GO:0055013 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 7.22e-04 | 169 | 180 | 7 | GO:0009154 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | MYO5A GAPDH ACAT1 ANXA1 ENPP1 ACLY ACOX1 POR BCAT2 CPT2 OGDH KAT2B FASN PLA2G4C GLDC AGT SCP2 ABCB11 HSD17B12 ENO1 | 7.34e-04 | 1035 | 180 | 20 | GO:0019752 |
| GeneOntologyBiologicalProcess | polyol metabolic process | 7.43e-04 | 123 | 180 | 6 | GO:0019751 | |
| GeneOntologyBiologicalProcess | isoleucine catabolic process | 7.44e-04 | 5 | 180 | 2 | GO:0006550 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 7.56e-04 | 277 | 180 | 9 | GO:1901617 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 7.75e-04 | 124 | 180 | 6 | GO:0009134 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 8.37e-04 | 281 | 180 | 9 | GO:0046434 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | MYH3 MYH6 AMPD3 GAPDH ACAT1 ENPP1 ACLY OGDH KAT2B FASN DHODH HSD17B12 ENO1 | 8.41e-04 | 533 | 180 | 13 | GO:0009259 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.78e-04 | 127 | 180 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 9.47e-04 | 177 | 180 | 7 | GO:0055007 | |
| GeneOntologyBiologicalProcess | lipid oxidation | 9.53e-04 | 129 | 180 | 6 | GO:0034440 | |
| GeneOntologyBiologicalProcess | visual perception | 9.57e-04 | 230 | 180 | 8 | GO:0007601 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | MYO5A GAPDH ACAT1 ANXA1 ENPP1 ACLY ACOX1 POR BCAT2 CPT2 OGDH KAT2B FASN PLA2G4C GLDC AGT SCP2 ABCB11 HSD17B12 ENO1 | 9.61e-04 | 1058 | 180 | 20 | GO:0043436 |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 9.78e-04 | 178 | 180 | 7 | GO:0009261 | |
| GeneOntologyBiologicalProcess | heart development | MYH6 NRAP ENPP1 DAG1 CHD7 KAT2A TGFB3 KAT2B HEY1 FDPS AGT EIF4G2 HEY2 MYO18B TNNT2 NIPBL | 1.01e-03 | 757 | 180 | 16 | GO:0007507 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.02e-03 | 349 | 180 | 10 | GO:0014706 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | MYO5A GAPDH ACAT1 ANXA1 ENPP1 ACLY ACOX1 POR BCAT2 CPT2 OGDH KAT2B FASN PLA2G4C GLDC AGT SCP2 ABCB11 HSD17B12 ENO1 | 1.03e-03 | 1064 | 180 | 20 | GO:0006082 |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 1.04e-03 | 233 | 180 | 8 | GO:0050953 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 1.05e-03 | 88 | 180 | 5 | GO:0003208 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 1.07e-03 | 132 | 180 | 6 | GO:0006661 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 1.07e-03 | 132 | 180 | 6 | GO:0009135 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 1.07e-03 | 132 | 180 | 6 | GO:0055006 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 1.07e-03 | 132 | 180 | 6 | GO:0009179 | |
| GeneOntologyBiologicalProcess | general adaptation syndrome, behavioral process | 1.11e-03 | 6 | 180 | 2 | GO:0051867 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 1.11e-03 | 6 | 180 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 1.11e-03 | 182 | 180 | 7 | GO:0006195 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 1.16e-03 | 24 | 180 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | coenzyme A metabolic process | 1.16e-03 | 24 | 180 | 3 | GO:0015936 | |
| GeneOntologyCellularComponent | myofibril | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 DAG1 KAT2B MYO18B TNNT1 TNNT2 ENO1 FKBP1B | 1.04e-07 | 273 | 179 | 14 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 DAG1 KAT2B MYO18B TNNT1 TNNT2 ENO1 FKBP1B | 2.18e-07 | 290 | 179 | 14 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 KAT2B MYO18B TNNT1 TNNT2 ENO1 FKBP1B | 2.46e-07 | 249 | 179 | 13 | GO:0030017 |
| GeneOntologyCellularComponent | myosin filament | 2.01e-06 | 25 | 179 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 MYO5A ANXA1 NUMA1 DAG1 EFHB DNAH7 KLHL22 KAT2B SYNJ1 FAM161A MID1 CCT8 BAIAP2 MYO18B TNNT1 TNNT2 ENO1 FKBP1B | 2.56e-05 | 1179 | 179 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1D MYH2 MYH3 FLNC MYH6 NRAP MYOM1 MYO5A ANXA1 NUMA1 DAG1 EFHB DNAH7 KLHL22 KAT2B SYNJ1 FAM161A MID1 CCT8 BAIAP2 MYO18B TNNT1 TNNT2 ENO1 FKBP1B | 2.87e-05 | 1187 | 179 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | myosin II complex | 9.06e-05 | 28 | 179 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 1.50e-04 | 59 | 179 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.19e-04 | 16 | 179 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.20e-04 | 107 | 179 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | I band | 5.81e-04 | 166 | 179 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | A band | 1.02e-03 | 52 | 179 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.27e-03 | 139 | 179 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | sarcolemma | 1.28e-03 | 190 | 179 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1D PACSIN1 ANXA1 HCN1 NTRK2 DAG1 SYNJ1 CNTNAP2 GPC4 AFDN BAIAP2 ENO1 EPB41L1 | 1.59e-03 | 583 | 179 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | mitotic spindle | 1.77e-03 | 201 | 179 | 7 | GO:0072686 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 NRAP ANXA1 DAG1 PTPRU LCK AQP7 ABCB4 EIF4G2 CNTNAP2 ABCB11 AFDN BAIAP2 | 1.79e-03 | 591 | 179 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | MYH2 FLNC NRAP ANXA1 DAG1 TNS2 PTPRU LCK PFN1 AQP7 ABCB4 PI4KA EIF4G2 CNTNAP2 ABCB11 AFDN BAIAP2 TNS1 | 1.84e-03 | 976 | 179 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | Z disc | 1.94e-03 | 151 | 179 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.07e-03 | 153 | 179 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | troponin complex | 2.52e-03 | 9 | 179 | 2 | GO:0005861 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 2.52e-03 | 9 | 179 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | myofilament | 2.55e-03 | 32 | 179 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.55e-03 | 32 | 179 | 3 | GO:0097470 | |
| Domain | Myosin-like_IQ_dom | 2.76e-05 | 19 | 178 | 4 | IPR027401 | |
| Domain | - | 2.76e-05 | 19 | 178 | 4 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 2.89e-05 | 38 | 178 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.89e-05 | 38 | 178 | 5 | PS51456 | |
| Domain | Myosin_head | 2.89e-05 | 38 | 178 | 5 | PF00063 | |
| Domain | MYSc | 2.89e-05 | 38 | 178 | 5 | SM00242 | |
| Domain | Hist_acetylase_PCAF | 9.03e-05 | 2 | 178 | 2 | IPR016376 | |
| Domain | PCAF_N | 9.03e-05 | 2 | 178 | 2 | IPR009464 | |
| Domain | PCAF_N | 9.03e-05 | 2 | 178 | 2 | PF06466 | |
| Domain | - | 9.72e-05 | 10 | 178 | 3 | 3.40.47.10 | |
| Domain | Thiolase-like | 9.72e-05 | 10 | 178 | 3 | IPR016039 | |
| Domain | IQ | 1.24e-04 | 81 | 178 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.21e-04 | 90 | 178 | 6 | IPR000048 | |
| Domain | ELM2_dom | 2.27e-04 | 13 | 178 | 3 | IPR000949 | |
| Domain | ELM2 | 2.27e-04 | 13 | 178 | 3 | PF01448 | |
| Domain | ELM2 | 2.27e-04 | 13 | 178 | 3 | PS51156 | |
| Domain | ELM2 | 2.27e-04 | 13 | 178 | 3 | SM01189 | |
| Domain | DUF3523 | 2.69e-04 | 3 | 178 | 2 | IPR021911 | |
| Domain | TNNT | 2.69e-04 | 3 | 178 | 2 | IPR027707 | |
| Domain | DUF3523 | 2.69e-04 | 3 | 178 | 2 | PF12037 | |
| Domain | Myosin_N | 3.56e-04 | 15 | 178 | 3 | PF02736 | |
| Domain | Myosin_N | 3.56e-04 | 15 | 178 | 3 | IPR004009 | |
| Domain | AAA | 4.66e-04 | 144 | 178 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 4.66e-04 | 144 | 178 | 7 | IPR003593 | |
| Domain | Tensin_PTB | 5.35e-04 | 4 | 178 | 2 | IPR033929 | |
| Domain | IQ | 5.82e-04 | 71 | 178 | 5 | PF00612 | |
| Domain | Myosin_tail_1 | 6.25e-04 | 18 | 178 | 3 | PF01576 | |
| Domain | Myosin_tail | 6.25e-04 | 18 | 178 | 3 | IPR002928 | |
| Domain | ABC_transporter_CS | 6.73e-04 | 42 | 178 | 4 | IPR017871 | |
| Domain | Thiolase_acyl_enz_int_AS | 8.86e-04 | 5 | 178 | 2 | IPR020615 | |
| Domain | ABC_tran | 1.12e-03 | 48 | 178 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.12e-03 | 48 | 178 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.21e-03 | 49 | 178 | 4 | PS00211 | |
| Domain | SANT | 1.30e-03 | 50 | 178 | 4 | SM00717 | |
| Domain | ABC_transporter-like | 1.30e-03 | 50 | 178 | 4 | IPR003439 | |
| Domain | Thiolase_C | 1.32e-03 | 6 | 178 | 2 | PF02803 | |
| Domain | BRK | 1.32e-03 | 6 | 178 | 2 | SM00592 | |
| Domain | Dilute_dom | 1.32e-03 | 6 | 178 | 2 | IPR002710 | |
| Domain | THIOLASE_2 | 1.32e-03 | 6 | 178 | 2 | PS00737 | |
| Domain | BRK_domain | 1.32e-03 | 6 | 178 | 2 | IPR006576 | |
| Domain | THIOLASE_1 | 1.32e-03 | 6 | 178 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 1.32e-03 | 6 | 178 | 2 | PS00099 | |
| Domain | Thiolase_N | 1.32e-03 | 6 | 178 | 2 | IPR020616 | |
| Domain | Thiolase_C | 1.32e-03 | 6 | 178 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 1.32e-03 | 6 | 178 | 2 | IPR020613 | |
| Domain | Thiolase | 1.32e-03 | 6 | 178 | 2 | IPR002155 | |
| Domain | Troponin | 1.32e-03 | 6 | 178 | 2 | PF00992 | |
| Domain | DIL | 1.32e-03 | 6 | 178 | 2 | PF01843 | |
| Domain | Thiolase_N | 1.32e-03 | 6 | 178 | 2 | PF00108 | |
| Domain | Troponin | 1.32e-03 | 6 | 178 | 2 | IPR001978 | |
| Domain | DILUTE | 1.32e-03 | 6 | 178 | 2 | PS51126 | |
| Domain | DIL | 1.32e-03 | 6 | 178 | 2 | SM01132 | |
| Domain | BRK | 1.32e-03 | 6 | 178 | 2 | PF07533 | |
| Domain | SANT/Myb | 1.51e-03 | 52 | 178 | 4 | IPR001005 | |
| Domain | IPK | 1.84e-03 | 7 | 178 | 2 | PF03770 | |
| Domain | IPK | 1.84e-03 | 7 | 178 | 2 | IPR005522 | |
| Domain | SANT_dom | 1.88e-03 | 26 | 178 | 3 | IPR017884 | |
| Domain | IQ | 1.96e-03 | 93 | 178 | 5 | PS50096 | |
| Domain | SANT | 2.34e-03 | 28 | 178 | 3 | PS51293 | |
| Domain | PTEN_C2 | 2.44e-03 | 8 | 178 | 2 | PF10409 | |
| Domain | PTB | 2.44e-03 | 8 | 178 | 2 | IPR013625 | |
| Domain | Sel1 | 2.44e-03 | 8 | 178 | 2 | PF08238 | |
| Domain | PTEN_C2 | 2.44e-03 | 8 | 178 | 2 | SM01326 | |
| Domain | SEL1 | 2.44e-03 | 8 | 178 | 2 | SM00671 | |
| Domain | PTB | 2.44e-03 | 8 | 178 | 2 | PF08416 | |
| Domain | C2_TENSIN | 2.44e-03 | 8 | 178 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 2.44e-03 | 8 | 178 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 2.44e-03 | 8 | 178 | 2 | IPR014020 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 3.35e-05 | 38 | 139 | 5 | M39549 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.88e-05 | 20 | 139 | 4 | M27881 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 6.44e-05 | 70 | 139 | 6 | M12294 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.75e-05 | 25 | 139 | 4 | M27880 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.06e-04 | 48 | 139 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.06e-04 | 48 | 139 | 5 | MM14589 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.86e-04 | 54 | 139 | 5 | M3896 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SEL1L PRPSAP2 DMGDH AMPD3 ABCA4 ZNF562 MYO5A KDM4C CHD7 RFTN2 CPT2 PFN1 OGDH MIER1 RCOR2 ELMO1 CDKAL1 POLR3F KAT2B TRMT10A ATAD3B SLC38A10 ATAD3C PLEKHM2 GLDC SUPT5H VANGL1 CEP250 DHODH DAAM2 USP4 | 4.28e-13 | 1242 | 181 | 31 | 30973865 |
| Pubmed | PRPSAP2 NCALD MYO5A GAPDH ACAT1 ANXA1 HCN1 NTRK2 HNRNPM DAG1 POR FAM91A1 OGDH ARFGEF3 ATAD3B ATAD3C SYNJ1 FDPS PI4KA EIF4G2 CNTNAP2 CCT8 AFDN BAIAP2 ENO1 EPB41L1 RBM17 | 5.26e-11 | 1139 | 181 | 27 | 36417873 | |
| Pubmed | PRPSAP2 ABCA4 MYO5A RTCB GAPDH ACAT1 PACSIN1 ANXA1 ACLY HNRNPM PFN1 OGDH TIAL1 SYNJ1 SV2B FDPS CCT8 ENO1 | 8.08e-10 | 552 | 181 | 18 | 36293380 | |
| Pubmed | SEL1L DMGDH MYH3 ZNF573 ZNF562 PNLIPRP2 PACSIN1 PENK DAG1 RDH5 POR SPAG7 DNAH7 SYNJ1 HEY1 SUPT5H FDPS ANKEF1 CCT8 HSD17B12 RCOR3 ATP13A3 RPGR TANGO2 PRIMPOL IP6K2 | 3.95e-09 | 1293 | 181 | 26 | 15342556 | |
| Pubmed | FLNC MYH6 MYO5A RTCB GAPDH ACAT1 PACSIN1 ANXA1 ACLY HNRNPM POR PFN1 OGDH FASN ATAD3B ATAD3C SYNJ1 SV2B PI4KA EIF4G2 CCT8 AFDN USP4 BAIAP2 TNNT2 TNS1 EPB41L1 | 7.36e-09 | 1431 | 181 | 27 | 37142655 | |
| Pubmed | MYO5A RTCB GAPDH ANXA1 ACLY POR LCK FASN SUPT5H VANGL1 EIF4G2 CCT8 RCOR3 ENO1 | 2.67e-08 | 399 | 181 | 14 | 37536630 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | DTD1 FLNC ZNF562 IPO7 MYO5A GAPDH ANXA1 HNRNPM PCMTD1 PI4KA DHODH CNTNAP2 GPC4 CCT8 ENO1 FKBP14 | 5.07e-08 | 564 | 181 | 16 | 21565611 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 FLNC IPO7 MYO5A RTCB GAPDH ACAT1 ANXA1 ACLY NUMA1 PFN1 FASN TIAL1 SUPT5H VANGL1 PI4KA CCT8 AFDN ENO1 NIPBL RBM17 | 1.01e-07 | 1024 | 181 | 21 | 24711643 |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 37801083 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | IPO7 GAPDH ANXA1 ACLY NUMA1 KAT2A LCK PFN1 TIAL1 CCT8 BAIAP2 ENO1 | 1.68e-07 | 327 | 181 | 12 | 15592455 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNC IPO7 MYO5A RTCB GAPDH ACAT1 ANXA1 ACLY NUMA1 HNRNPM CHD8 CHD7 SMARCAD1 PFN1 IFI16 FASN PIK3C2A FDPS PI4KA EIF4G2 CCT8 AFDN ENO1 NIPBL | 1.70e-07 | 1353 | 181 | 24 | 29467282 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.83e-07 | 268 | 181 | 11 | 33024031 | |
| Pubmed | MYO5A GAPDH ACAT1 PACSIN1 ACLY OGDH FASN SYNJ1 SV2B CCT8 BAIAP2 ENO1 EPB41L1 | 2.24e-07 | 403 | 181 | 13 | 30562941 | |
| Pubmed | 6.82e-07 | 14 | 181 | 4 | 36706168 | ||
| Pubmed | 8.01e-07 | 61 | 181 | 6 | 27166947 | ||
| Pubmed | FLNC RTCB GAPDH ACAT1 ANXA1 ACLY HNRNPM PFN1 FASN TIAL1 SUPT5H PI4KA EIF4G2 CCT8 AFDN ENO1 | 1.03e-06 | 707 | 181 | 16 | 19738201 | |
| Pubmed | IPO7 TTC28 GAPDH ACLY NUMA1 HNRNPM PFN1 CDKAL1 FASN VANGL1 EIF4G2 CCT8 HSD17B12 AFDN ENO1 EPB41L1 | 1.05e-06 | 708 | 181 | 16 | 39231216 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 1.30e-06 | 203 | 181 | 9 | 16916647 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 18089809 | ||
| Pubmed | IPO7 RTCB GAPDH ANXA1 ACLY SPAG7 CHD8 CHD7 KAT2A IFI16 KHDC4 ELMO1 FASN TIAL1 FDPS EIF4G2 CCT8 SCP2 NIPBL RBM17 | 1.41e-06 | 1103 | 181 | 20 | 34189442 | |
| Pubmed | MYH6 MYOM1 GAPDH ACAT1 BCAT2 CPT2 OGDH ATAD3B ATAD3C TNNT2 ENO1 | 1.47e-06 | 331 | 181 | 11 | 29199018 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 VRK1 IPO7 RTCB GAPDH ACAT1 ACLY NUMA1 HNRNPM POR SMARCAD1 PFN1 OGDH FASN SUPT5H PI4KA EIF4G2 CCT8 HSD17B12 AFDN MYO18B ENO1 NIPBL | 1.59e-06 | 1425 | 181 | 23 | 30948266 |
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.60e-06 | 17 | 181 | 4 | 27725084 | |
| Pubmed | 1.60e-06 | 17 | 181 | 4 | 16124007 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | GAPDH ANXA1 ENPP1 HNRNPM POR DHODH EIF4G2 CCT8 HSD17B12 ENO1 | 1.64e-06 | 269 | 181 | 10 | 30442662 |
| Pubmed | FLNC IPO7 RTCB GAPDH ACAT1 ENPP1 ACLY HNRNPM PFN1 FASN ATAD3B CCT8 HSD17B12 | 1.74e-06 | 484 | 181 | 13 | 31995728 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANXA1 DAG1 FAM91A1 PFN1 TTC7A FASN SYNJ1 PI4KA EIF4G2 CCT8 AFDN BAIAP2 ENO1 EPB41L1 | 1.77e-06 | 565 | 181 | 14 | 25468996 |
| Pubmed | THOC1 SEL1L BCL2L14 MYH2 IPO7 RTCB NUMA1 PGAP4 PFN1 IFI16 OGDH CDKAL1 ARFGEF3 FASN ATAD3B PIK3C2A FDPS EIF4G2 CCT8 HSD17B12 ATP13A3 ENO1 RBM17 | 1.89e-06 | 1440 | 181 | 23 | 30833792 | |
| Pubmed | FLNC IPO7 GAPDH ANXA1 ACLY NUMA1 HNRNPM PFN1 KLHL22 FASN TIAL1 CCT8 ENO1 | 2.17e-06 | 494 | 181 | 13 | 26831064 | |
| Pubmed | MYH3 FLNC NRAP IPO7 MYOM1 GAPDH PIK3C2A EIF4G2 HEY2 RCOR3 MYO18B TNNT1 ENO1 | 2.32e-06 | 497 | 181 | 13 | 23414517 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 2.43e-06 | 281 | 181 | 10 | 30455355 | |
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 24366871 | ||
| Pubmed | 4.78e-06 | 7 | 181 | 3 | 16819597 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNC RTCB GAPDH ACAT1 ANXA1 ACLY NUMA1 HNRNPM CHD8 PFN1 OGDH FASN SLC13A4 CCT8 DAAM2 ENO1 | 5.59e-06 | 807 | 181 | 16 | 30575818 |
| Pubmed | PRPSAP2 IPO7 RTCB GAPDH ACLY HNRNPM FASN ATAD3B CCT8 HSD17B12 RBM17 | 5.92e-06 | 383 | 181 | 11 | 29331416 | |
| Pubmed | MYH2 MYH3 FLNC MYH6 NCALD MYO5A NUMA1 HNRNPM KAT2A OGDH ABCB4 FASN ATAD3B ATAD3C TIAL1 FAM161A GPC4 TMPRSS7 USPL1 TNNT1 ENO1 NIPBL | 6.66e-06 | 1442 | 181 | 22 | 35575683 | |
| Pubmed | MYH2 ABCA4 IPO7 TTC28 CHD7 PRDM5 DNAH7 ATAD3B ZNF665 KDM2B RCOR3 C5 FER1L5 NIPBL | 7.11e-06 | 638 | 181 | 14 | 31182584 | |
| Pubmed | 7.12e-06 | 250 | 181 | 9 | 18660489 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 7.27e-06 | 135 | 181 | 7 | 29859926 | |
| Pubmed | FLNC IPO7 GAPDH ANXA1 NUMA1 HNRNPM PFN1 FASN CCT8 ENO1 RBM17 | 8.30e-06 | 397 | 181 | 11 | 21319273 | |
| Pubmed | 9.21e-06 | 327 | 181 | 10 | 31409639 | ||
| Pubmed | FLNC IPO7 MYO5A RTCB ACAT1 ANXA1 ACLY NUMA1 CHD8 CHD7 FASN SUPT5H AFDN NIPBL | 9.23e-06 | 653 | 181 | 14 | 22586326 | |
| Pubmed | 9.46e-06 | 259 | 181 | 9 | 9811942 | ||
| Pubmed | 9.73e-06 | 197 | 181 | 8 | 31620119 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 1.13e-05 | 27 | 181 | 4 | 18649358 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | THOC1 VRK1 RTCB GAPDH ACAT1 NUMA1 HNRNPM CHD8 CHD7 ATAD3B TIAL1 EIF4G2 CCT8 AFDN ENO1 NIPBL RBM17 | 1.14e-05 | 954 | 181 | 17 | 36373674 |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 1.17e-05 | 202 | 181 | 8 | 33601422 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYO5A GAPDH ANXA1 ACLY HNRNPM KAT2A PFN1 OGDH FASN CCT8 BAIAP2 ENO1 TNS1 | 1.22e-05 | 580 | 181 | 13 | 35676659 |
| Pubmed | MYO5A HCN1 NTRK2 NUMA1 HNRNPM CHD8 CHD7 RCOR2 SYNJ1 PI4KA CCT8 AFDN BAIAP2 ENO1 TNS1 NIPBL EPB41L1 | 1.28e-05 | 963 | 181 | 17 | 28671696 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 1.39e-05 | 343 | 181 | 10 | 28130547 | |
| Pubmed | TTC28 GAPDH HNRNPM POR FAM91A1 PFN1 DNAH7 ARFGEF3 PLEKHM2 VANGL1 PI4KA CCT8 AFDN RPGR BAIAP2 | 1.51e-05 | 777 | 181 | 15 | 35844135 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 1.55e-05 | 210 | 181 | 8 | 26217791 | |
| Pubmed | SEL1L PRPSAP2 IPO7 RTCB GAPDH ACAT1 ENPP1 ACLY NUMA1 SMARCAD1 PFN1 EDEM3 FASN FOXRED2 VANGL1 CCT8 HSD17B12 TTC13 NIPBL RBM17 | 1.55e-05 | 1297 | 181 | 20 | 33545068 | |
| Pubmed | 1.82e-05 | 104 | 181 | 6 | 36055981 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | SEL1L GAPDH ACAT1 ACLY POR PFN1 CDKAL1 FASN CCT8 HSD17B12 TTC13 ENO1 | 1.85e-05 | 516 | 181 | 12 | 36610398 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.96e-05 | 357 | 181 | 10 | 37059091 | |
| Pubmed | 2.00e-05 | 31 | 181 | 4 | 21985497 | ||
| Pubmed | 2.15e-05 | 64 | 181 | 5 | 20889312 | ||
| Pubmed | HeyL regulates the number of TrkC neurons in dorsal root ganglia. | 2.22e-05 | 11 | 181 | 3 | 19631204 | |
| Pubmed | Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1. | 2.22e-05 | 11 | 181 | 3 | 37254794 | |
| Pubmed | Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. | 2.38e-05 | 109 | 181 | 6 | 29111324 | |
| Pubmed | THOC1 VRK1 IPO7 ACAT1 ANXA1 NUMA1 CHD8 SMARCAD1 KAT2A IFI16 POLR3F FASN SUPT5H EIF4G2 CCT8 NIPBL RBM17 | 2.47e-05 | 1014 | 181 | 17 | 32416067 | |
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 2.50e-05 | 110 | 181 | 6 | 18307411 | |
| Pubmed | Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice. | 2.69e-05 | 2 | 181 | 2 | 30416103 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31886153 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 30624931 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35691019 | ||
| Pubmed | Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. | 2.69e-05 | 2 | 181 | 2 | 11792844 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 16890614 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10562721 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 34270849 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 2.69e-05 | 2 | 181 | 2 | 20453063 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10594058 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 2.69e-05 | 2 | 181 | 2 | 33526815 | |
| Pubmed | HERP, a new primary target of Notch regulated by ligand binding. | 2.69e-05 | 2 | 181 | 2 | 11486044 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10449439 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 30091450 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 39191188 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22408025 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 12381474 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 16763017 | ||
| Pubmed | Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells. | 2.69e-05 | 2 | 181 | 2 | 11018265 | |
| Pubmed | Identification of a region within SEL1L protein required for tumour growth inhibition. | 2.69e-05 | 2 | 181 | 2 | 14729273 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15077010 | ||
| Pubmed | Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. | 2.69e-05 | 2 | 181 | 2 | 19795461 | |
| Pubmed | ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population. | 2.69e-05 | 2 | 181 | 2 | 23022423 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23453247 | ||
| Pubmed | Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI. | 2.69e-05 | 2 | 181 | 2 | 24790181 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19408031 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 24366234 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 2.69e-05 | 2 | 181 | 2 | 24096970 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15502373 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 25361534 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 29103441 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26735860 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11027331 | ||
| Pubmed | Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? | 2.69e-05 | 2 | 181 | 2 | 10451243 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 29451493 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17264802 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26845599 | ||
| Interaction | SDR42E2 interactions | 2.69e-06 | 4 | 178 | 3 | int:SDR42E2 | |
| Interaction | USP48 interactions | PRPSAP2 ABCA4 MYO5A RTCB GAPDH ACAT1 PACSIN1 ANXA1 ACLY HNRNPM PFN1 OGDH PPIC TIAL1 SYNJ1 SV2B FDPS CCT8 ENO1 | 7.60e-06 | 668 | 178 | 19 | int:USP48 |
| Interaction | SHANK3 interactions | MYO5A GAPDH ACAT1 PACSIN1 ACLY HCN1 NUMA1 ARFGEF3 SYNJ1 FDPS PI4KA CCT8 BAIAP2 ENO1 EPB41L1 RBM17 | 8.88e-06 | 496 | 178 | 16 | int:SHANK3 |
| Interaction | LGALS9 interactions | FLNC IPO7 RTCB GAPDH ACAT1 SLC26A2 ENPP1 ACLY PIEZO1 HNRNPM DAG1 PFN1 FASN ATAD3B CCT8 HSD17B12 ATP13A3 | 1.91e-05 | 588 | 178 | 17 | int:LGALS9 |
| GeneFamily | Myosin heavy chains | 1.19e-04 | 15 | 119 | 3 | 1098 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.07e-04 | 53 | 119 | 4 | 532 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 4.24e-04 | 5 | 119 | 2 | 902 | |
| GeneFamily | EF-hand domain containing|Troponin complex subunits | 1.17e-03 | 8 | 119 | 2 | 1219 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.17e-03 | 8 | 119 | 2 | 837 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.59e-03 | 76 | 119 | 4 | 743 | |
| GeneFamily | ATP binding cassette subfamily B | 2.27e-03 | 11 | 119 | 2 | 806 | |
| GeneFamily | ATAC complex | 3.20e-03 | 13 | 119 | 2 | 1058 | |
| GeneFamily | ATP binding cassette subfamily A | 3.71e-03 | 14 | 119 | 2 | 805 | |
| Coexpression | ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR | 5.99e-06 | 100 | 180 | 7 | M39218 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN | 1.06e-05 | 200 | 180 | 9 | M6018 | |
| Coexpression | GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP | 1.06e-05 | 200 | 180 | 9 | M4093 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.42e-05 | 158 | 180 | 8 | M9147 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CACNA1D IPO7 MYO5A RTCB ACAT1 ACLY CHD7 CDC37L1 ELMO1 KAT2B FASN ABCA5 PIK3C2A PI4KA RCOR3 ENO1 TNS1 EPB41L1 MAP3K2 | 2.98e-05 | 946 | 180 | 19 | M39169 |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 3.81e-05 | 55 | 180 | 5 | MM397 | |
| Coexpression | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 | 5.81e-05 | 60 | 180 | 5 | M2018 | |
| Coexpression | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 | 6.81e-05 | 62 | 180 | 5 | MM865 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP | 7.35e-05 | 199 | 180 | 8 | M9600 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 7.35e-05 | 199 | 180 | 8 | M3191 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP | 7.61e-05 | 200 | 180 | 8 | M5999 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 7.61e-05 | 200 | 180 | 8 | M9336 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_12H_BMDC_DN | 7.61e-05 | 200 | 180 | 8 | M3949 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN | 7.61e-05 | 200 | 180 | 8 | M6184 | |
| Coexpression | GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN | 7.61e-05 | 200 | 180 | 8 | M7347 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP | 7.61e-05 | 200 | 180 | 8 | M6356 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN | 7.61e-05 | 200 | 180 | 8 | M5693 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE | 8.66e-05 | 13 | 180 | 3 | M40988 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 1.28e-04 | 408 | 180 | 11 | M3284 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | MYH2 MYH3 FLNC NCALD MYOM1 INPP5A HCN1 PCMTD1 IFI16 SCN7A ATP13A3 TNNT1 TNNT2 TNS1 | 3.80e-06 | 388 | 173 | 14 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | MYH2 MYH3 FLNC MYH6 NCALD MYOM1 INPP5A HCN1 RDH5 PGAP4 PCMTD1 IFI16 KAT2B SV2B SCN7A GPC4 ATP13A3 TNNT1 TNNT2 TNS1 | 4.17e-06 | 761 | 173 | 20 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_100 | 1.79e-05 | 100 | 173 | 7 | PCBC_ctl_geo-heart_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | BCL2L14 MYH6 MYOM1 ANXA1 ENPP1 NTRK2 PENK PCMTD1 IFI16 ELMO1 ABCA5 PIK3C2A GLDC SCN7A APOL5 CNTNAP2 ATP13A3 TNNT1 TNNT2 | 1.91e-05 | 774 | 173 | 19 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 6.13e-05 | 164 | 173 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_500 | 6.44e-05 | 122 | 173 | 7 | gudmap_developingGonad_P2_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | BCL2L14 MYH2 MYH3 MYOM1 ENPP1 IFI16 SCN7A CNTNAP2 ATP13A3 TNNT1 TNNT2 TNS1 | 8.48e-05 | 388 | 173 | 12 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CACNA1D PNLIPRP2 ERN1 PIEZO1 DAG1 BCAT2 CHD7 PCMTD1 DNAH7 IFNAR2 PIK3C2A HEY1 GPC4 ATP13A3 TNNT1 ENO1 EPB41L1 IP6K2 | 8.50e-05 | 791 | 173 | 18 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500 | BCL2L14 MYH6 MYOM1 ENPP1 PENK PCMTD1 IFI16 ELMO1 PIK3C2A SCN7A CNTNAP2 TNNT2 | 8.90e-05 | 390 | 173 | 12 | gudmap_developingLowerUrinaryTract_P1_ureter_500 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.75e-08 | 184 | 181 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-07 | 197 | 181 | 9 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-07 | 200 | 181 | 9 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.10e-06 | 189 | 181 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.14e-06 | 190 | 181 | 8 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 197 | 181 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 199 | 181 | 8 | 399e73d45638848e68edda120316ceff04d98680 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 199 | 181 | 8 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-06 | 200 | 181 | 8 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-06 | 160 | 181 | 7 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.28e-06 | 170 | 181 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | (00)_Basal-(0)_uninjured|(00)_Basal / shred by cell type and Timepoint | 9.81e-06 | 182 | 181 | 7 | c02c9cab4389d80f318f4bb8d703c1e719672624 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.05e-05 | 184 | 181 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 184 | 181 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 185 | 181 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 181 | 7 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 181 | 7 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.30e-05 | 190 | 181 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.39e-05 | 192 | 181 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 192 | 181 | 7 | be75783d9578974b662e1cb13bd3442a921fd50a | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 192 | 181 | 7 | 4fc98f30f8e738816cd93101fbe8ac40889e302a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 193 | 181 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 193 | 181 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-05 | 194 | 181 | 7 | 1ac52b00ea0b0ddbd04f5d85fa8c086980a78926 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.48e-05 | 194 | 181 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 195 | 181 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 196 | 181 | 7 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.59e-05 | 196 | 181 | 7 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-05 | 197 | 181 | 7 | 367aaf277c56962c96ddb4de06949fb33fc6170b | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 198 | 181 | 7 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-05 | 198 | 181 | 7 | 81c4c5377d0901ee9594424f08b0e4101686c850 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease, Lineage and Cell Type | 1.75e-05 | 199 | 181 | 7 | dbc10835ca4af08311e25e30f00b6c8bf9ccc3d3 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 181 | 7 | 6fa339666c4032b29ac521e88f0e917a57013cde | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-05 | 200 | 181 | 7 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | proximal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 181 | 7 | e9a008bfe336002218c63d1c2231986e1b237621 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 181 | 7 | 5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | b99249a0de31adab6cc342e276a6b6dfe8d2481c | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 3.08e-05 | 147 | 181 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-05 | 159 | 181 | 6 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-05 | 159 | 181 | 6 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.95e-05 | 160 | 181 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 167 | 181 | 6 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 168 | 181 | 6 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 168 | 181 | 6 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 169 | 181 | 6 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 169 | 181 | 6 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 169 | 181 | 6 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.93e-05 | 170 | 181 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.16e-05 | 171 | 181 | 6 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-05 | 172 | 181 | 6 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 172 | 181 | 6 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 172 | 181 | 6 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | TCGA-Brain-Primary_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.64e-05 | 173 | 181 | 6 | f6ba22661e67c17d49d1058d4170ba8f36bf47f0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 7.88e-05 | 174 | 181 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 175 | 181 | 6 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 175 | 181 | 6 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.39e-05 | 176 | 181 | 6 | 7762e5d7c11756da605a604a289216bb53e25869 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.39e-05 | 176 | 181 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 177 | 181 | 6 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 177 | 181 | 6 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.66e-05 | 177 | 181 | 6 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 8.66e-05 | 177 | 181 | 6 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 177 | 181 | 6 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.66e-05 | 177 | 181 | 6 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 9.21e-05 | 179 | 181 | 6 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 181 | 6 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.50e-05 | 180 | 181 | 6 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.50e-05 | 180 | 181 | 6 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.79e-05 | 181 | 181 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.85e-05 | 113 | 181 | 5 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.85e-05 | 113 | 181 | 5 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 182 | 181 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 182 | 181 | 6 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 182 | 181 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 182 | 181 | 6 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 183 | 181 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 181 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 184 | 181 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | Control-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.07e-04 | 184 | 181 | 6 | 88b1a4c9a96a99fc3a39f7a2c3d0838739606f3e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.10e-04 | 185 | 181 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 185 | 181 | 6 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 185 | 181 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 186 | 181 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-04 | 186 | 181 | 6 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.21e-04 | 188 | 181 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 188 | 181 | 6 | 00c5259bcb83218b7d44f4d585d9b68ef49763ab | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-04 | 188 | 181 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.24e-04 | 189 | 181 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 189 | 181 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 189 | 181 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-04 | 189 | 181 | 6 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 189 | 181 | 6 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 189 | 181 | 6 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 190 | 181 | 6 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 190 | 181 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 191 | 181 | 6 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 191 | 181 | 6 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.31e-04 | 191 | 181 | 6 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| Drug | AC1Q5PO8 | 7.09e-08 | 28 | 179 | 6 | CID000000642 | |
| Drug | S-(-)-Etomoxir | 9.65e-08 | 100 | 179 | 9 | CID000060765 | |
| Drug | blebbistatin | 3.47e-07 | 116 | 179 | 9 | CID003476986 | |
| Drug | sterol | DTD1 ABCA4 ACAT1 ACLY ACOX1 POR ABCB4 FASN FDPS APOL5 SCP2 ABCB11 | 1.34e-06 | 265 | 179 | 12 | CID000001107 |
| Drug | 1,2-dithiol-3-thione | DTD1 CACNA1D FLNC IPO7 ERN1 GAPDH ANXA1 ACLY POR PEX12 RFTN2 PTPRU ABCB4 FASN CD86 FDPS EIF4G2 SCP2 HSD17B12 ENO1 TNS1 | 2.46e-06 | 829 | 179 | 21 | ctd:C049325 |
| Drug | Thimerosal | SEL1L ATG10 MYO5A PACSIN1 BCAT2 PGAP4 PFN1 IFI16 CDC37L1 RCOR2 ELMO1 ARFGEF3 KAT2B FASN TRMT10A TRPM3 PIK3C2A VANGL1 CD86 ANKEF1 MID1 CNTNAP2 ATP13A3 ENO1 NIPBL EPB41L1 | 2.59e-06 | 1199 | 179 | 26 | ctd:D013849 |
| Drug | formycin triphosphate | 2.92e-06 | 51 | 179 | 6 | CID000122274 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | TTC28 ESR1 GTDC1 CDKAL1 KLHL22 EDEM3 PLEKHM2 ASB7 FBXO42 RCOR3 | 3.32e-06 | 194 | 179 | 10 | 6958_DN |
| Drug | pyrophosphate | DTD1 PRPSAP2 MYH2 MYH3 MYH6 MYO5A GAPDH ENPP1 POR LCK OGDH PIK3C2A FDPS DHODH AFDN MYO18B IPMK IP6K2 | 4.37e-06 | 654 | 179 | 18 | CID000001023 |
| Drug | POPC | AMPD3 ANXA1 ACLY ACOX1 POR ABCB4 FASN PLA2G4C PIK3C2A PI4KA SCP2 ABCB11 | 5.89e-06 | 306 | 179 | 12 | CID000065167 |
| Drug | purealin | 6.26e-06 | 58 | 179 | 6 | CID006419303 | |
| Drug | AC1L1AH5 | 8.23e-06 | 215 | 179 | 10 | CID000000986 | |
| Drug | Gold | ERN1 GAPDH ACOX1 POR SMARCAD1 CPT2 OGDH ABCB4 EDEM3 SCP2 BAIAP2 ENO1 NIPBL IPMK | 8.75e-06 | 432 | 179 | 14 | ctd:D006046 |
| Drug | CoA group | GAPDH ACAT1 ACLY ACOX1 ESR1 BCAT2 KAT2A CPT2 OGDH KAT2B FASN PLA2G4C FDPS ABCB11 | 8.98e-06 | 433 | 179 | 14 | CID000000317 |
| Drug | K-Cl | CACNA1D MYH2 MYH3 MYH6 AMPD3 MYO5A GAPDH ESR1 PENK PFN1 AQP7 TGFB3 AGT HSD17B12 AFDN MYO18B | 1.12e-05 | 567 | 179 | 16 | CID000004873 |
| Drug | AC1NRBPQ | 1.32e-05 | 137 | 179 | 8 | CID005288569 | |
| Drug | clenbuterol | 1.71e-05 | 142 | 179 | 8 | CID000002783 | |
| Drug | Clofibric Acid | THOC1 SEL1L DMGDH INPP5A ACOX1 POR BCAT2 CPT2 PFN1 ABCB4 SLC38A10 SUPT5H FDPS AGT DHODH SCP2 ABCB11 EPB41L1 | 1.83e-05 | 727 | 179 | 18 | ctd:D002995 |
| Drug | nickel chloride | SEL1L AMPD3 GAPDH SLC26A2 ACLY ACOX1 ESR1 POR CHD7 OGDH KHDC4 CDC37L1 EGFL6 TGFB3 EDEM3 KAT2B FASN TIAL1 GLDC CD86 FDPS AGT DHODH TNS1 | 1.84e-05 | 1178 | 179 | 24 | ctd:C022838 |
| Drug | fast white | 1.91e-05 | 42 | 179 | 5 | CID000024008 | |
| Drug | Superoxides | 1.96e-05 | 105 | 179 | 7 | ctd:D013481 | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 6273_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.82e-05 | 198 | 179 | 9 | 7303_DN | |
| Drug | EMD 57033 | 2.91e-05 | 23 | 179 | 4 | CID000187079 | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.93e-05 | 199 | 179 | 9 | 4294_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 3.05e-05 | 200 | 179 | 9 | 6947_DN | |
| Drug | lecithin | AMPD3 PNLIPRP2 ACAT1 ACLY ACOX1 NUMA1 POR ABCB4 PLA2G4C PIK3C2A ABCB11 | 3.14e-05 | 305 | 179 | 11 | CID010425705 |
| Drug | Nitrofurantoin | 3.47e-05 | 24 | 179 | 4 | ctd:D009582 | |
| Drug | B0683 | 3.96e-05 | 117 | 179 | 7 | CID006398969 | |
| Drug | AC1L194G | 4.09e-05 | 49 | 179 | 5 | CID000000386 | |
| Drug | bexarotene | ACAT1 ACOX1 ESR1 POR CPT2 AQP7 TGFB3 FASN SCP2 ABCB11 HSD17B12 ENO1 TNS1 | 4.48e-05 | 437 | 179 | 13 | ctd:C095105 |
| Drug | 1r5h | 5.51e-05 | 10 | 179 | 3 | CID000448288 | |
| Drug | salicyl | 5.63e-05 | 27 | 179 | 4 | CID000010252 | |
| Drug | tasosartan | 6.15e-05 | 2 | 179 | 2 | ctd:C086167 | |
| Drug | benziodarone | 6.15e-05 | 2 | 179 | 2 | ctd:C058702 | |
| Drug | tipranavir | 6.15e-05 | 2 | 179 | 2 | ctd:C107201 | |
| Drug | ditekiren | 6.15e-05 | 2 | 179 | 2 | ctd:C050898 | |
| Drug | Methyltestosterone | 6.58e-05 | 54 | 179 | 5 | ctd:D008777 | |
| Drug | Cholic Acids | 6.67e-05 | 127 | 179 | 7 | ctd:D002793 | |
| Drug | AC1L3NLD | 7.52e-05 | 29 | 179 | 4 | CID000092184 | |
| Drug | perfluorohexanesulfonic acid | 7.90e-05 | 176 | 179 | 8 | ctd:C471071 | |
| Drug | succinate | GAPDH ACAT1 SLC26A2 ACOX1 POR OGDH TGFB3 SLC13A4 PIK3C2A DHODH ENO1 | 8.14e-05 | 339 | 179 | 11 | CID000001110 |
| Drug | Amiodarone | MYH6 NRAP ERN1 RTCB GAPDH ACAT1 ENPP1 HCN1 ACOX1 POR PEX12 CPT2 GTDC1 OGDH DNAH7 EGFL6 ABCB4 FASN SLC13A4 CD86 ASB7 FDPS AGT ABCB11 TNNT1 ENO1 | 8.63e-05 | 1469 | 179 | 26 | ctd:D000638 |
| Drug | Rotenone | LILRB3 ATG10 ERN1 GAPDH ACAT1 ENPP1 INPP5A NTRK2 ESR1 HNRNPM SPAG7 DNAH7 CDKAL1 FASN SV2B AGT TNNT1 TNNT2 FKBP1B NIPBL | 9.16e-05 | 978 | 179 | 20 | ctd:D012402 |
| Drug | sodium pentaborate | 1.26e-04 | 33 | 179 | 4 | ctd:C538809 | |
| Drug | hexadecanedioic acid | 1.26e-04 | 33 | 179 | 4 | CID000010459 | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 189 | 179 | 8 | 5254_DN | |
| Drug | pyridaben | 1.33e-04 | 99 | 179 | 6 | ctd:C428725 | |
| Drug | hydroxyl radicals | PRPSAP2 DMGDH AMPD3 ABCA4 PNLIPRP2 GAPDH ACAT1 SLC26A2 ANXA1 ENPP1 INPP5A ACOX1 POR PTPRU LCK CPT2 ABCB4 FASN PLA2G4C SYNJ1 MID1 DHODH USP4 ENO1 | 1.40e-04 | 1341 | 179 | 24 | CID000000961 |
| Drug | pyruvic acid | GAPDH ACAT1 ACLY ACOX1 BCAT2 CPT2 OGDH TGFB3 FASN PIK3C2A DHODH ENO1 | 1.41e-04 | 424 | 179 | 12 | CID000001060 |
| Drug | verapamil | CACNA1D MYH2 MYH3 MYH6 ABCA4 MYO5A ABCB4 TGFB3 ABCA5 PIK3C2A AGT SCN7A ABCB11 | 1.41e-04 | 490 | 179 | 13 | CID000002520 |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 4118_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 2520_DN | |
| Drug | epicholesterol | ABCA4 PNLIPRP2 ACAT1 ACLY ACOX1 POR ABCB4 TGFB3 FASN ABCA5 PIK3C2A FDPS APOL5 SCP2 ABCB11 | 1.59e-04 | 636 | 179 | 15 | CID000000304 |
| Drug | naringin | 1.60e-04 | 146 | 179 | 7 | ctd:C005274 | |
| Drug | 5666823; Down 200; 100uM; MCF7; HG-U133A | 1.61e-04 | 195 | 179 | 8 | 609_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 3971_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 2888_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.66e-04 | 196 | 179 | 8 | 987_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 6785_UP | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1D ATG10 INPP5A LCK PFN1 KAT2B PIK3C2A PI4KA AGT EIF4G2 FKBP1B EPB41L1 IPMK IP6K2 | 1.69e-04 | 568 | 179 | 14 | CID000000806 |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 4239_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 3292_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2269_DN | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; HL60; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2194_UP | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; PC3; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 7149_UP | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; HL60; HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2037_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 1635_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2095_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 1541_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 5492_UP | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 7203_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 2909_UP | |
| Drug | Fish Oils | 1.81e-04 | 149 | 179 | 7 | ctd:D005395 | |
| Drug | AC1N9ZZC | 1.81e-04 | 149 | 179 | 7 | CID004369374 | |
| Drug | NSC134727 | 1.83e-04 | 3 | 179 | 2 | CID000281834 | |
| Drug | alpha-bromo-4-chlorophenylacetic acid | 1.83e-04 | 3 | 179 | 2 | CID010490868 | |
| Drug | 2-fluoromyristic acid | 1.83e-04 | 3 | 179 | 2 | CID000177754 | |
| Drug | l-945 | 1.83e-04 | 3 | 179 | 2 | CID000097919 | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 6132_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5787_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 4741_DN | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5994_UP | |
| Drug | dexamethasone; Down 200; 1uM; MCF7; HG-U133A | 1.85e-04 | 199 | 179 | 8 | 123_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 7255_DN | |
| Drug | alkylbenzene | 1.85e-04 | 67 | 179 | 5 | CID000031237 | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.91e-04 | 200 | 179 | 8 | 7336_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.91e-04 | 200 | 179 | 8 | 3056_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.91e-04 | 200 | 179 | 8 | 1524_UP | |
| Drug | erucyl-CoA | 2.03e-04 | 15 | 179 | 3 | CID006443765 | |
| Drug | AND-CoA | 2.03e-04 | 107 | 179 | 6 | CID003083159 | |
| Disease | unipolar depression, bipolar disorder, mental or behavioural disorder | 4.26e-06 | 6 | 178 | 3 | EFO_0000677, EFO_0003761, MONDO_0004985 | |
| Disease | Cerebral Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0750936 | |
| Disease | Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.47e-05 | 25 | 178 | 4 | C0547065 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 1.47e-05 | 25 | 178 | 4 | C4551472 | |
| Disease | Pilocytic Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.47e-05 | 25 | 178 | 4 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.73e-05 | 26 | 178 | 4 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.73e-05 | 26 | 178 | 4 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.73e-05 | 26 | 178 | 4 | C0334582 | |
| Disease | Anaplastic astrocytoma | 2.02e-05 | 27 | 178 | 4 | C0334579 | |
| Disease | Hypertrophic Cardiomyopathy | 2.45e-05 | 57 | 178 | 5 | C0007194 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Gastrointestinal defect and immunodeficiency syndrome | 3.62e-05 | 2 | 178 | 2 | cv:C5234880 | |
| Disease | distal myopathy (implicated_via_orthology) | 4.56e-05 | 12 | 178 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.56e-05 | 12 | 178 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | Acute Coronary Syndrome | 4.57e-05 | 33 | 178 | 4 | C0948089 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.90e-05 | 13 | 178 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.12e-05 | 71 | 178 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 9.31e-05 | 15 | 178 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 1.08e-04 | 3 | 178 | 2 | C0268312 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 1.08e-04 | 3 | 178 | 2 | cv:C1865643 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 1.08e-04 | 3 | 178 | 2 | C4551899 | |
| Disease | kidney disease (implicated_via_orthology) | 1.09e-04 | 41 | 178 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.14e-04 | 16 | 178 | 3 | EFO_0008297 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.26e-04 | 80 | 178 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.02e-04 | 48 | 178 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 2.15e-04 | 4 | 178 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | neuromuscular disease (implicated_via_orthology) | 2.15e-04 | 4 | 178 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 2.15e-04 | 4 | 178 | 2 | C4551898 | |
| Disease | brain age measurement | 2.28e-04 | 20 | 178 | 3 | EFO_0010602 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.37e-04 | 50 | 178 | 4 | C1449563 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.66e-04 | 206 | 178 | 7 | C0152013 | |
| Disease | Other restrictive cardiomyopathy | 3.58e-04 | 5 | 178 | 2 | C0348616 | |
| Disease | sick sinus syndrome (is_implicated_in) | 3.58e-04 | 5 | 178 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Atrial septal defect | 3.58e-04 | 5 | 178 | 2 | cv:C0018817 | |
| Disease | Ureteral obstruction | 3.98e-04 | 24 | 178 | 3 | C0041956 | |
| Disease | Sick Sinus Syndrome | 5.34e-04 | 6 | 178 | 2 | C0037052 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 5.34e-04 | 6 | 178 | 2 | EFO_0802705 | |
| Disease | inclusion body myositis (is_implicated_in) | 5.34e-04 | 6 | 178 | 2 | DOID:3429 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 5.34e-04 | 6 | 178 | 2 | EFO_0801767 | |
| Disease | adipoylcarnitine (C6-DC) measurement | 5.34e-04 | 6 | 178 | 2 | EFO_0800380 | |
| Disease | testosterone measurement | CACNA1D MYH2 AMPD3 TTC28 MYO5A ESR1 DAG1 POR CHD7 RFTN2 CDC37L1 IFNAR2 KAT2B FASN SERPINB8 TLL1 CNTNAP2 DAAM2 | 7.38e-04 | 1275 | 178 | 18 | EFO_0004908 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 7.45e-04 | 7 | 178 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 7.45e-04 | 7 | 178 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 7.45e-04 | 7 | 178 | 2 | C0597124 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 8.57e-04 | 31 | 178 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Cholestasis of pregnancy | 9.89e-04 | 8 | 178 | 2 | C0268318 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 9.89e-04 | 8 | 178 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Henoch-Schoenlein purpura (is_implicated_in) | 9.89e-04 | 8 | 178 | 2 | DOID:11123 (is_implicated_in) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.27e-03 | 9 | 178 | 2 | DOID:264 (is_marker_for) | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.27e-03 | 9 | 178 | 2 | C0949658 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.27e-03 | 9 | 178 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Ostium secundum atrial septal defect | 1.27e-03 | 9 | 178 | 2 | C0344724 | |
| Disease | cholestasis (implicated_via_orthology) | 1.27e-03 | 9 | 178 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | electrocardiography | MYH6 PACSIN1 GRK7 HCN1 TRPM3 CNTNAP2 HEY2 BAIAP2 MYO18B TNNT2 | 1.49e-03 | 530 | 178 | 10 | EFO_0004327 |
| Disease | Obesity | 1.58e-03 | 205 | 178 | 6 | C0028754 | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 1.92e-03 | 11 | 178 | 2 | EFO_0800074 | |
| Disease | autistic disorder (is_implicated_in) | 2.08e-03 | 42 | 178 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Seizures | 2.15e-03 | 218 | 178 | 6 | C0036572 | |
| Disease | liver cirrhosis (is_implicated_in) | 2.23e-03 | 43 | 178 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | phenylacetylglutamine measurement | 2.30e-03 | 12 | 178 | 2 | EFO_0021013 | |
| Disease | microphthalmia (implicated_via_orthology) | 2.30e-03 | 12 | 178 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.30e-03 | 12 | 178 | 2 | DOID:3319 (is_marker_for) | |
| Disease | complement factor D measurement | 2.46e-03 | 93 | 178 | 4 | EFO_0020283 | |
| Disease | pleurisy (implicated_via_orthology) | 2.70e-03 | 13 | 178 | 2 | DOID:10247 (implicated_via_orthology) | |
| Disease | selective IgA deficiency disease | 2.71e-03 | 46 | 178 | 3 | EFO_1001929 | |
| Disease | Cardiomyopathy | 2.88e-03 | 47 | 178 | 3 | cv:C0878544 | |
| Disease | Cardiomyopathy, Dilated | 3.06e-03 | 48 | 178 | 3 | C0007193 | |
| Disease | Left ventricular noncompaction | 3.14e-03 | 14 | 178 | 2 | C1960469 | |
| Disease | Hypermetropia | 3.56e-03 | 103 | 178 | 4 | HP_0000540 | |
| Disease | P wave duration | 3.61e-03 | 15 | 178 | 2 | EFO_0005094 | |
| Disease | Sinus Node Dysfunction (disorder) | 3.61e-03 | 15 | 178 | 2 | C0428908 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.11e-03 | 16 | 178 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | pancreatic carcinoma | 4.17e-03 | 174 | 178 | 5 | EFO_0002618 | |
| Disease | Mouth Neoplasms | 4.27e-03 | 54 | 178 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 4.27e-03 | 54 | 178 | 3 | C0153381 | |
| Disease | Congestive heart failure | 4.50e-03 | 110 | 178 | 4 | C0018802 | |
| Disease | Heart failure | 4.50e-03 | 110 | 178 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 4.50e-03 | 110 | 178 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 4.50e-03 | 110 | 178 | 4 | C0235527 | |
| Disease | Heart Decompensation | 4.50e-03 | 110 | 178 | 4 | C1961112 | |
| Disease | Myocardial Failure | 4.50e-03 | 110 | 178 | 4 | C1959583 | |
| Disease | Necrosis | 4.50e-03 | 55 | 178 | 3 | C0027540 | |
| Disease | protein C measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0004633 | |
| Disease | major depressive disorder (is_implicated_in) | 4.64e-03 | 17 | 178 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | copine-1 measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0008102 | |
| Disease | urinary albumin to creatinine ratio | 4.70e-03 | 179 | 178 | 5 | EFO_0007778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAAKHMAGLKVYNVD | 301 | Q8TAA9 | |
| LQEHFEIYGAVKGMS | 1391 | Q8WWZ7 | |
| GMKVQFGASHVFKFV | 486 | P55196 | |
| MFYHQKHFQLGLKGT | 126 | Q14236 | |
| GVFKHGYEKYNTMRA | 1636 | Q9HCK8 | |
| GFYMAVPALAGHKKD | 431 | Q8IUX8 | |
| YKKLGFINHVNPAMD | 356 | Q92556 | |
| LSMFAKKAGAHSVYA | 191 | Q6P2P2 | |
| KDLIGGFTALHYAAM | 76 | Q9H672 | |
| AEHMLFYAQLKGKSQ | 1021 | P78363 | |
| MGTIQHLKSKFGDGY | 2151 | P78363 | |
| HLKSKFGDGYIVTMK | 2156 | P78363 | |
| VGKYTMVFHTRDKGN | 281 | O60513 | |
| IYEKHSAGLTKGMHA | 171 | Q9H7F0 | |
| EKGTHEELMAQKGAY | 1296 | O95342 | |
| KALMGHFQDGLSYSV | 231 | Q9BZR8 | |
| NRKGHSAMDVAKAYA | 621 | Q9NU02 | |
| GYMCKIHFQIKNGSV | 41 | Q9H0Y0 | |
| GKEKFDSVHSKYMGR | 71 | P42081 | |
| IGVFKHGYEKYNSMR | 1796 | Q9P2D1 | |
| TYVHFQGKMKGFSLL | 271 | P01019 | |
| GGILFVYDNKKMLEH | 226 | Q01432 | |
| SKYHGQLTKEAAMGQ | 536 | P23786 | |
| AKEKHGYNIEQALGM | 96 | Q8IZ40 | |
| KEKHGYNVEQALGML | 51 | Q9P2K3 | |
| AKRGMKFVGFISQHY | 151 | Q52LD8 | |
| QVKGYGTHLMNHLKE | 586 | Q92830 | |
| YCEKGFSKNDGLKMH | 521 | Q9NQX1 | |
| EESHLLAKRYGGFMK | 91 | P01210 | |
| AFFAEKLHQAMKGVG | 276 | P04083 | |
| EKMFSAYQRHQKELG | 641 | Q86T65 | |
| LIKGVAHQCYHGFMK | 81 | Q6P3S6 | |
| KTKGGDLMLVHYEGY | 41 | Q9NWM8 | |
| KMLQATGGKGYFDAH | 101 | Q9UBP5 | |
| NAKKLSMYGVDLHHA | 276 | Q9H4G0 | |
| GAMEHAQAVDYIKKL | 651 | P16435 | |
| FMNKYHGRKLSVQGF | 271 | Q9UHH9 | |
| QVKGYGTHLMNHLKE | 581 | Q92831 | |
| HAMKVGSLASNVAYK | 431 | Q86VF7 | |
| AEKSLNDMFVKTYGH | 116 | O75487 | |
| YMAGIDGEKEHANAK | 281 | P14324 | |
| KLGNQVLEMFDHAYG | 51 | Q9BZQ6 | |
| VSMYCRLGFAHKKGQ | 286 | Q658Y4 | |
| CGHVLYADIKMENGK | 676 | P52272 | |
| GKHEYFMHATDKGGL | 571 | Q14118 | |
| GAGVQKDHENYMKIL | 166 | Q96MG8 | |
| KAFFKRSIQGHNDYM | 206 | P03372 | |
| FGGKNYEASMSHVDK | 56 | Q14642 | |
| HESKMIEKHGGYKFS | 1006 | O95373 | |
| KFLGHAQMFGSFKRD | 1271 | O00443 | |
| TGAVMHYGNLKFKQK | 356 | Q9UKX2 | |
| KGLHQMGIKYDGNHI | 1831 | Q14315 | |
| KAKIAFGQSMDLHYT | 71 | Q9Y2U5 | |
| DKKYAGFIHMKAVAG | 2346 | Q6KC79 | |
| AMATESILHFAGYNK | 1101 | P42356 | |
| KYLAYMESKGAHRAG | 31 | Q9H3R0 | |
| KLYGAKYFGSNIAHM | 951 | Q9H3R0 | |
| MGYYNGHTKVAVKSL | 261 | P06239 | |
| ISDHGMEQGSCKKYI | 421 | P22413 | |
| SQKGYHHFVLMKEGE | 146 | Q6PI73 | |
| SQKGYHHFVLMKEGE | 146 | O75022 | |
| GLGSVAHMVLNKKYG | 51 | O14520 | |
| AHMVLNKKYGSYLGV | 56 | O14520 | |
| LSQVYCHKGFGKDMA | 351 | Q9BRR3 | |
| RKAKHGLFVINMEYG | 486 | Q8IWF2 | |
| GGKFMKSQGLSQLYH | 426 | P78344 | |
| MAQRSGKITLYEGKH | 1 | Q8WXF5 | |
| HQVAGHMYGKDKVGI | 51 | Q8NFU5 | |
| VYSGEQITMLKGHYK | 321 | Q13216 | |
| HKPEIKGNMSGNFTY | 181 | P48551 | |
| QGSHSELMKKEGVYF | 611 | P21439 | |
| QHINQMKTAEGYGFK | 881 | Q92729 | |
| YHKQIMGGFKETKEA | 121 | Q9BY11 | |
| KFIQAFGDGMKHCYK | 296 | Q8NGU1 | |
| AEYMAFGSLLKEGIH | 656 | Q02218 | |
| HNFLYKHGGIRDKIM | 361 | Q9UP65 | |
| LIKDGKFGAYMQVHI | 121 | Q8TEA8 | |
| RYMGKGVSKAVEHIN | 56 | P06733 | |
| MKSYDQVHSGKLVCG | 436 | Q15067 | |
| GAVGKKMYFIQHGVA | 506 | O60741 | |
| HKMISYNGKLYVFGG | 481 | Q96M94 | |
| VYAHAGATLEGKMYI | 436 | Q53GT1 | |
| SQLYQGDFVHAMEGK | 76 | Q8NHM5 | |
| MLEYLGKDVLHGVFN | 71 | P51878 | |
| VDYKMSHFVSNGDGL | 191 | O75460 | |
| HYTGMLQNGKKFDSS | 26 | P68106 | |
| EVDIYESGKHFMKGQ | 476 | Q5VV42 | |
| VHGGNKSEMKEYLVG | 1306 | Q5TH69 | |
| GALHNYKMTDKNFLG | 1321 | P01031 | |
| MEQEFFKGYLKGEHG | 161 | Q9BV73 | |
| QSHAEYMERFGKKGK | 81 | Q8WXX0 | |
| GIGKSYAEELAKHGM | 61 | Q53GQ0 | |
| FAKKLALHSGMDYAI | 186 | Q5T2N8 | |
| ASGNIVYGVFMLHKK | 311 | Q16666 | |
| GVSLAYHLAKAGMKD | 61 | Q9UI17 | |
| LLAAFRHYDKKGDGM | 566 | Q8N7U6 | |
| SGMHYVQDKLFVGLE | 226 | Q7Z7F0 | |
| LKMLHTAGGKGYFDA | 101 | Q9Y5J3 | |
| KERGAYKIFVMATHG | 286 | O60256 | |
| MFRHKGTYHTNEAKG | 1286 | Q9UHC6 | |
| HVASYGMSGAEKLQK | 101 | A6NKP2 | |
| MAAEKHYSNTLKALG | 566 | Q3B820 | |
| MNGGDLKFHIYNVGT | 271 | Q8WTQ7 | |
| MSILIIEAFYGGSHK | 1 | Q4AE62 | |
| VEDAFRYMAQGKHIG | 1836 | P49327 | |
| HYSLQLFEGMKAFKG | 96 | O15382 | |
| FSYGHCQIKDMVKAG | 571 | Q9UKG4 | |
| GLAFHAYGKAGKMLV | 71 | Q9HBR0 | |
| GHLSMEEFKKIYGNF | 41 | P61601 | |
| LKMTTFGAFLHKGAF | 936 | Q01668 | |
| ESFMQKYEQKIRHFG | 156 | Q7L3B6 | |
| NMGEKHLFVDLGVYT | 271 | Q96LW4 | |
| MGHYADQFKGKTSAV | 326 | P54317 | |
| GKKKYNLHPGVTDYM | 346 | Q8N108 | |
| ASYAEQLSMLKKAHG | 1431 | Q14980 | |
| KQGKYSGVGLLDHMT | 396 | Q86T96 | |
| GMLHYKAGTSYLGKE | 776 | Q8IWE5 | |
| HSAVVTGNNKLYMFG | 46 | Q92834 | |
| EIFNEYAAKKMGIDH | 236 | Q9Y3I0 | |
| KKVLSNMGAHFGGYL | 151 | P13805 | |
| NFKLKHYGIGWVSMA | 121 | P45877 | |
| GGLINKKCYEMASHL | 121 | P07737 | |
| MEDGYKGKILHFLQD | 381 | Q9H4L7 | |
| KLNYAIFDEGHMLKN | 621 | Q9H4L7 | |
| AKDAAHMLQANKTYG | 176 | O75391 | |
| KMKVFFGEHVYGATI | 426 | Q7L1I2 | |
| LGDHAMSKKRGALYQ | 96 | O43897 | |
| VNFDYHQMVKGGKAE | 331 | O43426 | |
| NAGNSHAMAFLGKMY | 406 | Q9UBV2 | |
| NETALHYFKKAADMG | 431 | Q9UBV2 | |
| FEVSIGHYGNKMDLN | 526 | A0AVI2 | |
| YFSMAASKGNAIGLH | 361 | Q5TEA6 | |
| FVMGVNHEKYDNSLK | 131 | P04406 | |
| NYGSKAIHLEGQKGM | 161 | Q5VWT5 | |
| GFDKHGEAVDGLYKM | 96 | Q02127 | |
| EKSGLYKLTGAVMHY | 346 | P11055 | |
| KEGTVGSVDGHMKLY | 256 | Q9H1D9 | |
| KDGLTDVYNKIHMGS | 181 | P24752 | |
| YFKMGDHVKVIAGRF | 471 | O00267 | |
| EKAGVYKLTGAIMHY | 346 | P13533 | |
| FYGLKRIVMGDTHKS | 86 | O00623 | |
| MEKYGTKIEHFAKIG | 171 | P22307 | |
| HYGGAFLTKYLKMQQ | 236 | Q92781 | |
| FHLYLMHKGGKLSVA | 206 | P0DPD7 | |
| AKFKMGYADEVHTQV | 201 | P50452 | |
| VAAMVYPFTGDHKQK | 526 | P53396 | |
| SMGFIGHYLDQKRLK | 1066 | P53396 | |
| FIAMGKNYEKALAGV | 31 | Q9UQB8 | |
| KDLHAYQMAKSNSGF | 241 | Q9BWW9 | |
| FAKKLALHSGMDYAI | 361 | Q5T9A4 | |
| EYGKDEKQISAHFMG | 366 | Q16620 | |
| KGKNNMGEAFYTVKL | 61 | Q9H7R5 | |
| KGFKYFASLDNHMGI | 211 | Q6V9R5 | |
| KGLSHVAMGQFYEGI | 391 | Q8NBP0 | |
| VAMGQFYEGIKAQTK | 396 | Q8NBP0 | |
| HMVGYLGKNFDSAKV | 26 | Q5W0Q7 | |
| AMGVGHYTAYAKNKL | 876 | Q13107 | |
| YGYLKQHQKIHTGMK | 426 | Q86YE8 | |
| YPEQSKGFHKAGSML | 211 | Q496A3 | |
| AHLGMYVQGNAKFVS | 661 | Q7RTY8 | |
| SEMFAKKHGYTVKAN | 401 | P50443 | |
| SHSFYSVNMKDKGGI | 1361 | Q9HCF6 | |
| GTVAHKIMQKYGFRE | 236 | Q96I25 | |
| HGLQSGTKYIFMVKA | 451 | O15344 | |
| REVAQMLKSKHGGNY | 41 | Q9HBL0 | |
| KALSNMMHFGGYIQK | 186 | P45379 | |
| MQCGKVFKSHSGLSY | 176 | O95780 | |
| KLAKFGLYHMTAHGD | 131 | Q8TEA7 | |
| SGLHDKNGKSYRFMI | 116 | Q99986 | |
| QSAYDGAKKMAHQLK | 1561 | Q8IUG5 | |
| GIIHQMKGDYDTALK | 481 | Q96AY4 | |
| GSYMEQHGVKFLRKF | 381 | Q86VQ6 | |
| MAAKGAHGSYLKVES | 1 | Q9ULT0 | |
| EMFYGGERSKHLKNG | 886 | Q01118 | |
| FYLTSHGGQLKKNMD | 141 | Q8TBZ6 | |
| LAKGGTVEYANEKHM | 2311 | Q92508 | |
| KCGKGYNSKFNLDMH | 516 | Q9NZL3 | |
| QGIKKMEGHYVHAGN | 51 | Q9P0M9 | |
| FAQMLKEGAKHFSGL | 11 | P50990 | |
| YNKLDAENAIVHMGG | 146 | Q01085 | |
| MERGHKYDVFGKIFN | 66 | Q86T29 | |
| YAKEIHKFDMIQGLA | 101 | P10600 | |
| GKLGVIVSAYMHYSK | 236 | Q63HR2 | |
| EQLKSVLEMYGHFSG | 471 | Q6PFW1 | |
| MEELKTGGEHVYFAK | 286 | Q96FV9 | |
| LKKVSMEGHLYNGFN | 106 | Q6ICL3 | |
| DKYGNIDAVHLKAMV | 671 | P23378 | |
| HCLKQYSGEEGFMKH | 1566 | Q9Y4I1 | |
| KGKYVMELFDGKTGH | 1526 | P52179 |